EUVIMEDEUVIMED entdecken
Crossref

Allium macrostemon Bge. delays chronic renal failure by modulating IL-17 signaling pathway and affecting tryptophan/glycerophospholipid metabolism

Yuan Zhao, Jing-Xin Ge, Na Zhang, Zhou-Xuan Lei, Sai-Yu Sun, Zhuo-Wei Luo, Yan-Fang Yang, He-Zhen Wu

Journal of Ethnopharmacology · 2026

DOI: 10.1016/j.jep.2025.120946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026. Verfasst von Yuan Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China; Hubei Key Laboratory of Chinese Medicine Resources and Chinese Medicin…. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Allium, Interleukin-17, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Hunan Normal University Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research Ministry of Education of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: In traditional Chinese medicine (TCM), Allium macrostemon Bge. (AMB) is characterized as warm-natured, acrid-bitter, and frequently employed to treat disorders associated with imbalances in water metabolism, such as edema. Modern pharmacological studies have shown that AMB has anti-atherosclerotic, hypolipidemic, anti-inflammatory and antioxidant effects. Chronic renal failure (CRF), one of the most prevalent chronic diseases worldwide, is categorized within the "edema" spectrum and poses a significant challenge to global healthcare systems, with its progression closely associated with inflammation. However, the role and mechanism of action of AMB in delaying CRF have not been fully investigated. AIM OF THE STUDY: This study aimed to investigate the improvement effect of AMB on CRF and the potential mechanism by in vitro and in vivo experiments. MATERIALS AND METHODS: In vitro experiments, the effective part of AMB was screened through the MPC5 cell injury model induced by Adriamycin (ADM), and the efficacy was verified in the HK-2 cell model. The delaying effect of the n-butanol fraction (NF) on CRF rats was studied by UPLC-MS/MS combined with high-throughput screening. RNA-seq and bioinformatics techniques were used to analyze the differentially expressed genes (DEGs) and pathways in MPC5 cells. Molecular docking was used to verify the interaction between the components entering the blood and the key pathway proteins. In vivo experiments were conducted by intragastric administration of adenine for 3 weeks to establish a CRF rat model. Niaoduqing granules (NDQG) was used as the positive control. Different concentrations of the active components were intragastrically administered for 4 weeks. The pathological damage of the kidneys was evaluated by HE and Masson staining. The disease indicators and pathway protein levels were detected by ELISA and immunohistochemistry. In the in vitro model, after adding pathway inhibitors, qPCR was used to detect the expression of downstream genes. Broad-targeted metabolomics analysis was performed on the differential metabolites in the serum and enrichment was carried out, and important proteins were used to verify the mechanism. RESULTS: Both in vitro and in vivo experiments confirmed AMB's significant chronic renal failure (CRF)-improving efficacy. RNA-seq combined with clinical databases revealed AMB protected injured MPC5 cells by downregulating IL-17 pathway genes (CXCL2, CXCL5, LCN2, CEBPβ, IL-6). The qPCR results showed that AMB exerted its therapeutic effect highly dependent on the IL-17 pathway and had a synergistic effect with C25-140. Serum metabolome results showed that AMB exerted its therapeutic effects by affecting glycerophospholipid metabolism and tryptophan metabolism. Immunohistochemistry validated changes in these target proteins. CONCLUSIONS: AMB delays CRF by regulating the IL-17 pathway and affecting tryptophan metabolism and glycerophospholipid metabolism, providing a scientific basis for its clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Failure, ChronicAlliumInterleukin-17Plant ExtractsAnimalsMaleSignal TransductionRats, Sprague-DawleyRatsHumansCell LineDisease Models, AnimalChive

Stichwörter der Autor:innen

Allium macrostemon Bge.Chronic renal failureGlycerophospholipid metabolismIL-17 pathwayTryptophan metabolism

Substanzen

Interleukin-17Plant Extracts

Autor:innen und Institutionen

  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China; Hubei Key Laboratory of Chinese Medicine Resources and Chinese Medicine Chemistry, Wuhan, Hubei, China. Electronic address: 1253690464@qq.co…
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China; Hubei Key Laboratory of Chinese Medicine Resources and Chinese Medicine Chemistry, Wuhan, Hubei, China. Electronic address: 2601747402@qq.co…
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China; Hubei Key Laboratory of Chinese Medicine Resources and Chinese Medicine Chemistry, Wuhan, Hubei, China. Electronic address: 3047653603@qq.co…
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China; Hubei Key Laboratory of Chinese Medicine Resources and Chinese Medicine Chemistry, Wuhan, Hubei, China. Electronic address: 505840698@qq.com.
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, Hubei, China; Hubei Key Laboratory of Chinese Medicine Resources and Chinese Medicine Chemistry, Wuhan, Hubei, China. Electronic address: ssy441175@163.co…
  • First Clinical College, Hubei University of Chinese Medicine, Wuhan, China. Electronic address: 2765517933@qq.com.

Förderung

  • National Key Research and Development Program of China
  • Hunan Normal University Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research Ministry of Education of China

Zitieren

APA

Zhao, Y., Ge, J. X., Zhang, N., Lei, Z. X., Sun, S. Y., Luo, Z. W., Yang, Y. F., & Wu, H. Z. (2026). Allium macrostemon Bge. delays chronic renal failure by modulating IL-17 signaling pathway and affecting tryptophan/glycerophospholipid metabolism. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.120946

Vancouver

Zhao Y, Ge JX, Zhang N, Lei ZX, Sun SY, Luo ZW, et al. Allium macrostemon Bge. delays chronic renal failure by modulating IL-17 signaling pathway and affecting tryptophan/glycerophospholipid metabolism. Journal of Ethnopharmacology. 2026. doi:10.1016/j.jep.2025.120946

BibTeX
@article{Zhao2026,
  author = {Zhao, Yuan and Ge, Jing-Xin and Zhang, Na and Lei, Zhou-Xuan and Sun, Sai-Yu and Luo, Zhuo-Wei and Yang, Yan-Fang and Wu, He-Zhen},
  title = {Allium macrostemon Bge. delays chronic renal failure by modulating IL-17 signaling pathway and affecting tryptophan/glycerophospholipid metabolism},
  journal = {Journal of Ethnopharmacology},
  year = {2026},
  doi = {10.1016/j.jep.2025.120946}
}
Kostenlos starten →